Understanding SARS-CoV-2-Mediated Inflammatory Responses: From
Por um escritor misterioso
Descrição
Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness.
SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis
New research supports finding explaining why some patients may test positive for COVID-19 long after recovery
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions - Jiang - 2022 - MedComm - Wiley Online Library
Understanding Immune Responses to SARS-CoV-2
Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage
Testing Host Immune Responses and Transmissibility
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Covid-19 Effects on organs
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy, Journal of Biomedical Science
de
por adulto (o preço varia de acordo com o tamanho do grupo)
